Durham-based Priovant Therapeutics, with Roivant Sciences, has shared encouraging results from its Phase 3 VALOR study evaluating brepocitinib, a potential new treatment for the autoimmune disease ...

After a tumultuous 2025 for life sciences in North Carolina and across the country, what’s in store for one of the strongest economic engines in the Triangle? Join prominent figures as they discuss ...

Novonesis, a global leader in biosolutions, welcomed hundreds of local students, educators, and community leaders to its ...

Join BTEC for a lunch and learn on Oct. 24. Discover how sbi is transforming shake flask experiments with real-time DO, biomass, and fluorescence monitoring — bringing clarity, control, and confidence ...

Novonesis, a global leader in biosolutions, welcomed hundreds of local students, educators, and community leaders to its ...

Hosted by the RNA Discovery Center and the UNC Chapel Hill Department of Pharmacology, a screening of the new film "Cracking the Code: Phil Sharp and the Biotech Revolution," will be held on Oct. 22.

Join the North Carolina Regulatory Affairs Forum for its annual Round Table Dinner on Nov. 13. This event will feature a networking reception, followed by discussions at multiple tables. Each table ...

Parexel, a clinical research organization (CRO) providing clinical and consulting solutions to the life sciences industry, has opened its new global headquarters in Raleigh’s North Hills Innovation ...

Durham-based BioCryst Pharmaceuticals Inc. plans to acquire Boston-based Astria Therapeutics Inc., adding the late-stage hereditary angioedema (HAE) treatment, navenibart, to its portfolio. The ...

There is no cure yet for OA of the knee. Short-term measures such as oral pain medications, physical therapy or steroid injections into the knee can provide short-term relief. There are only a handful ...